FMXVF yields 6022.28% · PFE yields 6.13%● Live data
📍 FMXVF pulled ahead of the other in Year 1
Combined, FMXVF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FMXVF + PFE for your $10,000?
Amilot Capital Inc., a mineral resource company, acquires, explores for, develops, and exploits mineral properties in Canada and Colombia. It primarily explores for gold deposits. The company holds interest in the ANCAL property that includes 32 mining concessions, exploitation licenses, and applications covering an area of approximately 21,382 hectares situated in the Marmato/Caramanta districts in Colombia. It also holds interests in the NORTOL property, which consists of 29 mining concessions and applications covering an area of approximately 39,546 hectares located in Tolima district in Colombia; and the Papayo property that comprises approximately 400 meters of galleries covering an area of approximately 15,000 square meters located in the Tolima district in Colombia. The company was formerly known as Tolima Gold Inc. and changed its name to Amilot Capital Inc. in January 2019. The company is based in Toronto, Canada.
Full FMXVF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.